Skip to main content
. 2019 Aug 27;30(11):1821–1830. doi: 10.1093/annonc/mdz291

Figure 5.

Figure 5.

Co-occurring genomic alterations with HER2 amplification using the NCI-MATCH assay color coded by variant type (left): copy number variant (purple), single nucleotide variant (red), indel (pink) and number of variants (top) for each eligible patient along with information regarding histology and best response on treatment (bottom): partial response (PR), stable disease (SD), progression of disease (PD), unevaluable (UE).